Iindaba zeNkampani
Unyango lwe-BioOCUS Medical Group's Dual CD19/BCMA CAR-T luzisa iziphumo ezithembisayo kwi-Refractory Myasthenia Gravis: Uhambo lwesigulana esiselula
Impumelelo Kwezemfundo | Iqela Lezonyango laseLu Daopei Lipapasha Uphando Lweklinikhi Olumangalisayo kwiBritish Journal of Haematology
Iqela lezonyango laseLu Daopei, elikhokelwa nguGqr. Cao Xingyu kunye noNjingalwazi uLu Peihua, lipapashe iphepha lophando lwezonyango elibalulekileyo kwi Ijenali yaseBritane yeHaematology (Impact Factor 5.1). Olu phononongo luphanda ukhuseleko kunye nokusebenza kakuhle kokufakelwa kweeseli ze-hematopoietic stem cell (allo-HSCT) emva konyango lwe-autologous CD7 CAR-T kwi-T-cell engasebenziyo kunye ne-relaxated T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (R/R T-ALL/T-LBL).
Uphononongo lweMulti-Center lubonisa ukubikezela okuhle kwezigulana zeHematologic Malignancy ezifakelwa i-MMUD Allogeneic Stem Cell Transplant nge-ATG
Uphononongo olukhulu oluqhutywa ngamaziko amaninzi eTshayina lubonisa iziphumo ezilungileyo kwizigulana ezine-hematologic malignancies ezifakelwa iiseli ze-stem cell ezingafaniyo (MMUD) nge-ATG yokuthintela i-GVHD.
Ibali lesigulana: I-B-ALL enobungozi obukhulu, ukufakelwa kweBone Marrow kwiinyanga ezili-9, kwiminyaka emibini kamva—isiqalo esisempilweni somlwi oselula
Umntwana oneenyanga ezili-9 ubudala, ofunyaniswe ene-Acute B Lymphoblastic Leukemia (B-ALL) enobungozi obuphezulu, utyando lwe-bone marrow oluphumeleleyo. Emva kweminyaka emibini, umntwana ukhula kakuhle kwaye ulungele ukuya kwisikolo sabantwana abancinci.
Ukuqonda iThalassemia: Isikhokelo esipheleleyo kwiifom zeAlfa kunye neBeta
I-Thalassemia sisifo esingaphezulu kwesinye. Esi sikhokelo sihlola zombini i-alpha kunye ne-beta thalassemia, izizathu zazo, iimpawu, kunye neendlela zonyango zamva nje ezifumaneka kwi-BIOOCUS International Medical Center.
UDkt. Lu Peihua Uveza Impumelelo kwi-CAR-T Therapy kwiNtlanganiso yoNyaka yama-29 ye-APBMT
KwiNtlanganiso yoNyaka yama-29 ye-Asia-Pacific Blood and Marrow Transplantation (APBMT), uGqr. Lu Peihua unike intetho ephambili malunga nempumelelo yonyango lweeseli ze-CAR-T eTshayina. Idatha yokwenyani yeqela lakhe evela kunyango lwezonyango yamkelwe kwihlabathi liphela, ibonisa igalelo labo kunyango lwezifo ezibangelwa ligazi.
I-ASH 2024: Iqela likaLu Daopei libonisa iimpumelelo ezili-13 zophando kwiHematology
Kwingqungquthela ezayo ye-ASH 2024, iqela lezonyango leSibhedlele iLu Daopei liza kubonisa iziphumo zophando ezili-13 ezibalaseleyo, ligxininisa inkqubela phambili kwi-hematology kunye namathuba onyango lwe-CAR-T, liqinisekisa kwakhona ukuzibophelela kwabo ekuphuculeni iziphumo zesigulana.
Ukoyisa iLymphoma ngeDual CAR-T Therapy
Emva kokulwa ne-lymphoma iminyaka emithathu, umfazi oneminyaka engama-61 ubudala ufumene ukuphumla ngokupheleleyo ngonyango olutsha lwe-CAR-T oluphindwe kabini kwi-BIOOCUS, ebonisa amandla okutshintsha ubomi bonyango lomhlaza oluphambili.
I-Bioocus Ithatha Inxaxheba kwi-IGC 2024 ukuze Ihlole Ubudlelwane Obutsha kunye neeModeli zoShishino kwi-Immuno-Gene kunye noNyango lweeSeli
I-Bioocus inomdla wokujoyina iNgqungquthela yesi-8 ye-Immuno-Gene kunye neCell Therapy (IGC 2024)! Silangazelela ukusebenzisana neengcali zehlabathi kunye nokuhlola iimodeli ezintsha zoshishino ezihambelana nobuchwepheshe be-gene kunye ne-cell therapy obuphambili. Sisonke, masiyile ikamva le-immunotherapy.
Ukusebenza Okuphezulu Konyango lwe-CD7 CAR-T kwiZifo ze-B-Cell: Uphuhliso Olukhulu Kunyango Lomhlaza
Uphando lwamva nje lubonisa ukusebenza kakuhle kunye nokhuseleko lwe-CD7 CAR-T cell therapy ekunyangeni i-B-cell acute lymphoblastic leukemia (B-ALL) ephinde yabuyela kwi-relaxation okanye i-refractory kunye ne-T-cell lymphoblastic lymphoma (T-LBL). Olu phando luqhutywa yi-BIOOCUS ngokubambisana neSibhedlele iLu Daopei, lubonisa iziphumo ezithembisayo kwizigulana, zibonelela ngenye indlela enamandla endaweni ye-chemotherapy eqhelekileyo.
Ukusebenza kwexesha elide koNyango lwe-CD19 CAR T-Cell ekunyangeni i-Relapsed/Refractory Acute Lymphoblastic Leukemia
Uphononongo oluphambili lubonisa impumelelo yexesha elide yonyango lwe-CD19 CAR T-cell ekunyangeni izigulana ezine-relapse/refractory acute lymphoblastic leukemia (ALL) emva kokufakelwa kweeseli ze-hematopoietic stem, nto leyo enika ithemba elitsha kwi-hematology.
I-Bioocus Iqhubela Phambili Umda Ekunyangweni Kwe-Acute Lymphoblastic Leukemia Yabantwana
I-Bioocus iphambili ekuphuhliseni unyango lwe-CAR-T lwesizukulwana esilandelayo. Impapasho yakutshanje kaGqr. Chunrong Tong kunye neqela lakhe kwiSibhedlele saseLu Daopei igxininisa inkqubela phambili ebalulekileyo kunye nemingeni ekusetyenzisweni konyango lwe-CD19 CAR-T lwesizukulwana sesibini kwizigulana zabantwana, ibonisa ukuzinikela kweBioocus kunyango lomhlaza olutsha.